Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
21.02
+0.47 (2.29%)
At close: Sep 30, 2026
Liaoning Chengda Biotechnology Employees
Liaoning Chengda Biotechnology had 1,585 employees as of June 30, 2026. The number of employees decreased by 196 or -11.01% since the number was reported on December 31, 2025.
Employees
1,585
Change
-196
Growth
-11.01%
Revenue / Employee
858.53K CNY
Profits / Employee
26.99K CNY
Market Cap
8.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,585 | -196 | -11.01% |
| Dec 31, 2025 | 1,781 | -26 | -1.44% |
| Dec 31, 2024 | 1,807 | 75 | 4.33% |
| Dec 31, 2023 | 1,732 | 69 | 4.15% |
| Dec 31, 2022 | 1,663 | 134 | 8.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Novogene | 2,227 |
| Aurisco Pharmaceutical | 2,026 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Daan Gene | 1,506 |
| Bio-Thera Solutions | 1,471 |
| Chengdu Easton Biopharmaceuticals | 1,416 |